Preconceptional screening of sexually transmitted infections/diseases

Central European Journal of Medicine

Volumn 6, Issue 1, 2011, Pages 49-57

  Bánhidy, Ferenc ^a   DudáS, Istvan ^b   Czeizel, Andrew E ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

Author keywords

Preconceptional care; Preconceptional screening; Preterm birth; Sexually transmitted infection diseases; Vaginal candidosis

Indexed keywords

CLINDAMYCIN; CLOTRIMAZOLE; DOXYCYCLINE; METRONIDAZOLE;

ADULT; ARTICLE; ASYMPTOMATIC INFECTION; CHLAMYDIASIS; EVENING DOSAGE; FEMALE; GENITAL HERPES; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MORNING DOSAGE; MYCOPLASMA HOMINIS INFECTION; PREGNANCY; PREMATURE LABOR; PRENATAL SCREENING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONIASIS; UREAPLASMA INFECTION; VAGINA CANDIDIASIS; VAGINITIS;

EID: 79151470496     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-010-0049-y     Document Type: Article

References (53)

1. Czeizel AE, Dobo M, Dudas I et al.: The Hungarian Periconceptional Service as a model for community genetics. Community Genetics 1998, 1, 252-259
2. Czeizel AE: Ten years' experience in periconception care. Eur J Obstet Gynecol Reprod Biol 1999, 84, 43-49
3. Czeizel AE: Periconceptional Care: An experiment in community genetics. Community Genetics 2000, 3, 119-123
4. Czeizel AE, Dudás I: Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992, 328, 1832-1835
5. Czeizel AE, Dudás I, Métneki J: Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Final results. Arch Gynecol Obstet 1994, 255, 131-139
6. Czeizel AE: Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Br Med J 1993, 306, 1645-1648
7. Czeizel AE: Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1997, 62, 179-183
8. Czeizel AE, Dobo M, Vargha P: Hungarian cohort controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res (Part A) 2004, 70, 853-861
9. Czeizel AE: Periconceptional folic acid and multivitamin supplementation for the prevention of neural tube defects and other congenital abnormalities. Birth Defects Res (Part A) 2009, 85, 260-268
10. Gönczy L, Czeizel AE: Integrating smoking cessation into periconception care. Tob Control 1996, 5, 160-161
11. Czeizel AE, Dudás I, Fritz G: The check-up of reproductive heath and genetic counseling. Genet Counsel 1992, 3, 61-66
12. Hay Ph, Czeizel AE: Asymptomatic trichomonas and candida colonization and pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007, 21, 403-409
13. Czeizel AE, Gasztonyi Z, Kuliev A: Periconception clinics: A medical healthcare infrastructure of new genetics. Fetal Diagn Ther 2005, 20, 515-518
14. WHO: WHO Laboratory Manuel for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 3rd ed. Cambridge Univ. Press, Cambridge, 1992
15. Rothenberg RB, Simon R, Chipperfield E et al.: Efficacy of selected diagnostic tests for sexually transmitted diseases. JAMA 1976, 235, 49-51
16. Spence MR, Hollander DH, Smith J et al.: The clinical and laboratory diagnosis of Trichomonas vaginal infection. Sex Transm Dis 1980, 7, 198-171
17. Amsel R, Totten PA, Spiegel CA et al.: Nonspecific vaginitis: diagnostic criteria and microbial and epidemiological applications. Am J Med 1983, 74, 14-22
18. Donders GGG, Vereecken A, Dekeersmaecker A et al.: Wet mount reflects functional vaginal lactobacillary flora better than Gram stain. J Clin Pathol 2000, 53, 308-314.
19. Abbott J: Clinical and microscopic diagnosis of vaginal yeast infection: a prospective analysis. Ann Emerg Med 1995, 25, 587-591
20. Van der Schee C, van Belkum A, Zwijgers L et al.: Improved diagnosis of trichomonas vaginalis infection by PCR using vaginal swabs and urine specimens compared to diagnosis by wet mount microscopy, culture, and fluorescent staining. J Clin Microbiol 1999, 37, 4127-4130
21. Donders GGG: Microscopy of bacterial flora on fresh vaginal smears. Infect Dis Obstet Gynecol 1995, 7, 12-13
22. Spiegel CA, Amsel R, Holmes KK: Diagnosis of bacterial vaginosis by direct Gram-stain of vaginal fluid. J Clin Microbiol 1993, 18, 170-177
23. Sonnex C: The amine test: a simple, rapid, inexpensive method for diagnosing bacterial vaginosis. Br J Obstet Gynecol 1995, 102, 160-161
24. Nugent RP, Krohn MA, Hillier SL: Reliability of diagnosing bacterial vaginosis is improved by a standard method of Gram stain interpretation. J Clin Microbiol 1991, 29, 297-301
25. Donders GGG: Definition and classification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynaecol 2007, 21, 355-373
26. Donders GGG, Desmyter L, Vereecken A: Vaginitis. Lactobacillary grades and lactate producing bacteria in the vagina. N Engl J Med 1998, 338, 1548
27. Donders GGG, Vereecken A, Bosmans E et al.: Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. Br J Obstet Gynaecol 2002, 109, 1-10
28. Cibley LJ: Cytolytic vaginosis. Am J Obstet Gynecol 1991, 165, 1245-1249
29. Menon R, Fortunate SJ: Infection and the role of inflammation in preterm premature rupture of the membrane. Best Pract Res Clin Obstet Gynecol 2007, 21, 467-478
30. Bjerkedahl T, Czeizel AE, Hosmer DW: Birth weight of single livebirths and weight specific early neonatal mortality in Hungary and Norway. Paediat Perinat Epidemiol 1983, 3, 29-40
31. Divers MJ, Lilford RJ: Infection and preterm labor: a meta-analysis. Contemp Rev Obstet Gynecol 1993, 5, 71-84
32. Lettieri L, Vintaileos AM, Rodis JF, et al.: Does "idiopathic" preterm labor resulting in preterm birth exist? Am J Obstet Gynecol 1993, 168, 1480-1485
33. Chin BM, Lamon RF: The microbiology of preterm labor and delivery. Contemp Rev Obstet Gynaecol 1997, 9, 285-286
34. McGregor JA, French JI, Richter R et al.: Antenatal microbiological maternal risk factors associated with prematurity. Am J Obstet Gynecol 1990, 163, 1465-1473
35. Korn AP, Bolan G, Padian N et al.: Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet Gynecol 1981, 85, 387-388
36. Owen J, Groome LJ, Hauth JC: Randomised trial of prophylactic antibiotic therapy after preterm rupture. Amer J Obstet Gynecol 1993, 169, 976-981
37. Mercer BM, Miodovnik M, Thurnau GR, et al.: Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. J Am Med Ass 1997, 278, 989-995
38. Brucklehurst P, Hannah M, McDonald H: Interventions for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2000, (2), CD000262
39. Leitich H, Brunhauer M, Bodner-Adler B, et al.: Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. Am J Obstet Gynecol 2003, 188, 752-758
40. Romero R, Chaiworaponga T, Kuivaniemi H, Tromp G: Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 2004, 190, 1509-1519
41. Cotch MF, Hillier SL, Gibbs RS, Eschenback DA: Epidemiology and outcomes associated with moderate to heavy Candida colonisation during pregnancy. Am J Obstet Gynecol 1998, 178, 374-380
42. Czeizel AE, Rockenbauer M: A lower rate of preterm birth after clotrimazole therapy during pregnancy. Paediat Perinat Epid 1999, 13, 58-64
43. Czeizel AE, Fladung B, Vargha P: Preterm birth reduction after clotrimazole treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2004, 114, 157-163
44. Czeizel AE, Puhó E, Kazy Z: The use of data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities for the evaluation of birth outcomes beyond congenital abnormalities. Cent Eur J Publ Hlth 2007, 15, 147-153
45. Kiss H, Petricevic L, Husslein P: Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. Br Med J 2004, 329, 371-374
46. Okun N, Gronau KA, Hannah ME: Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol 2005, 105, 857-868
47. Genc MR, Schantz-Dunn J: The role of gene- environment interaction in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007, 21, 491-504
48. Kenyon SL, Taylor DJ, Tarnow-Mordi W: Broad spectrum antibiotics for spontaneous preterm labour: The ORACLE II. Randomized trial. ORACLE Collaborative Group. Lancet 2001, 357, 989-994
49. McGregor JA, French JI, Parker R, et al.: Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995, 173, 157-167
50. Lamont RF: Can antibiotics prevent preterm birth - the pro and con debate. Br J Obstet Gynaecol 2005, 112, Suppl.1, 67-73
51. Teichmann AT, Steigerwald U: Infektionen in Gynekologie und Geburtshilfe. Wissenschaftliche Verlagsgeselschaft. Stuttgart. 1994
52. Engelmann E. Sproßpilze. In: Hahn H, Falke D, Kaufmann SHE, Ullmann U (eds) Medizinische Mikrobiologie und Infektologie. Springer. Berlin. 1999. pp. 693-703
53. Ugwumadu A: Role of antibiotic therapy for bacterial vaginosis and intermediate flora in pregnancy. Best Pract Res Clin Obstet Gynaecol 2007, 21, 391-402